Mechanism and Antiviral Therapy in Preventing Mother-to-Child Transmission During Pregnancy with Hepatitis B Virus Infection

被引:1
|
作者
Zhao, Mengyu [1 ,2 ]
Zou, Huaibin [1 ,2 ]
Chen, Yu [1 ,2 ]
Duan, Zhongping [1 ]
机构
[1] Capital Med Univ, Beijing Youan Hosp, Difficult & Complicated Liver Dis & Artificial Li, Beijing, Peoples R China
[2] Beijing Municipal Key Lab Liver Failure & Artific, Beijing, Peoples R China
关键词
Antiviral Therapy; Hepatitis B Virus (HBV); Mother-to-Child Transmission (MTCT); Pregnancy; TENOFOVIR DISOPROXIL FUMARATE; CLINICAL-PRACTICE GUIDELINES; INFANT TRANSMISSION; SURFACE-ANTIGEN; INTRAUTERINE INFECTION; PERINATAL TRANSMISSION; VERTICAL TRANSMISSION; TELBIVUDINE TREATMENT; VACCINATION PROGRAM; HBV TRANSMISSION;
D O I
10.5812/hepatmon.81903
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Context: Mother-to-child transmission (MTCT) is one of the main transmission routes of chronic hepatitis B virus (HBV) infection. The successful rate of preventing MTCT has increased to over 90% after the administration of passive-active immunoprophylaxis (vaccine and hepatitis B immunoglobulin (HBIG)) on infants born to hepatitis B surface antigen (HBsAg)-positive mothers. However, 5%-10% of the infants had chronic HBV infection who were born to mothers with high HBV DNA levels. Therefore, the current domestic and international guidelines recommended that antiviral therapy in late pregnancy was to further decrease the MTCT rate. This study aimed at reviewing the mechanisms of MTCT and controversial issues in antiviral therapy for pregnant women with high viral load in order to provide clinicians with some strategies for preventing MTCT of HBV. Evidence Acquisition: Relevant English published papers were searched using online databases, including PubMed and EMBASE from January 2000 to January 2019. We summarized the findings of 61 relevant studies in this review. Results: The mechanism of MTCT is still unclear and further studies are needed. Antiviral therapy for pregnant women with high viral load can reduce the rate of MTCT and provide the appropriate safety for mothers and infants. Conclusions: The mechanisms underlying MTCT of HBV is still unknown and more investigations are required. The efficacy and safety of taking tenofovir disoproxil fumarate (TDF) orally in pregnant women with high viral load in the second or third trimester of pregnancy to block MTCT of HBV have been proved. The withdrawal of antiviral therapy during pregnancy due to MTCT should not exceed 3 months after delivery at the latest. Most pregnant women tend to suffer from increased alanine aminotransferase (ALT) after discontinuing antiviral drugs during pregnancy. Accordingly, close ALT levels monitoring after drug discontinuation is essential.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Global prevalence of hepatitis B virus infection and prevention of mother-to-child transmission
    Zhou, Yi-Hua
    Xu, Chenyu
    Chen, Tingmei
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (09): : 598 - 599
  • [22] Prevention strategies of mother-to-child transmission of hepatitis B virus (HBV) infection
    Hu Yao
    Yu Hui
    [J]. 儿科学研究(英文), 2020, 04 (02) : 133 - 137
  • [24] Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus
    Gentile, Ivan
    Zappulo, Emanuela
    Buonomo, Antonio Riccardo
    Borgia, Guglielmo
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (07) : 775 - 782
  • [25] Ethical issues in preventing mother-to-child transmission of hepatitis B by immunisation
    Isaacs, David
    Kilham, Henry A.
    Alexander, Shirley
    Wood, Nick
    Buckmaster, Adam
    Royle, Jenny
    [J]. VACCINE, 2011, 29 (37) : 6159 - 6162
  • [27] Is tenofovir the answer to further preventing mother-to-child transmission of hepatitis B?
    Hafidz, M. I. Abdul
    Tan, S-S
    Lee, Y. Y.
    [J]. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2016, 46 (04): : 248 - 250
  • [28] Enduring Challenges despite Progress in Preventing Mother-to-Child Transmission of Hepatitis B Virus in Angola
    Peliganga, Luis Baiao
    Horta, Marco Aurelio Pereira
    Lewis-Ximenez, Lia Laura
    [J]. PATHOGENS, 2022, 11 (02):
  • [29] Strategies to Prevent Mother-to-child Transmission of Hepatitis B Virus
    Sintusek, Palittiya
    Wanlapakorn, Nasamon
    Poovorawan, Yong
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (04) : 967 - 974
  • [30] Global prevalence of hepatitis B virus infection and prevention of mother-to-child transmission reply
    Razavi-Shearer, Devin
    Razavi, Homie
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (09): : 599 - 599